Processa Pharmaceuticals, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Oct 58-K/AOther events (amended)8.019.01
- Aug 1813GPassive stake of 5% or more (13G), filed by Soleus Capital Master Fund
- Aug 1410-QQuarterly report
- Aug 48-KOfficer or director change and shareholder vote5.025.079.01
- Jul 298-KMaterial agreement and acquisition or sale of assets completed1.011.022.013.025.025.037.019.01
- May 710-QQuarterly report
- Apr 308-KOfficer or director change5.029.01
- Mar 1810-KAnnual report
- Feb 198-KEnd of a material agreement1.029.01
- Jan 78-KOther events8.019.01
- Dec 15, 20258-KBylaws or fiscal year changed and change to shareholder rights3.035.039.01
- Nov 6, 202510-QQuarterly report
- Sep 16, 20258-K/ABylaws or fiscal year changed and shareholder vote (amended)5.035.079.01
- Sep 11, 20258-KShareholder vote5.079.01
- Sep 10, 20258-KShareholder vote5.07
- Sep 2, 20258-KShareholder vote5.07
- Aug 25, 20258-KOther events8.019.01
- Aug 14, 20258-K/AMaterial agreement and unregistered sale of shares (amended)1.013.027.019.01
- Aug 8, 20258-KListing notice or transfer3.019.01
- Aug 7, 202510-QQuarterly report
- Aug 7, 20258-KMaterial agreement and unregistered sale of shares1.013.027.019.01
- Jul 25, 20258-KOther events8.019.01
- Jul 25, 2025424B5Prospectus for an offering
- Jul 18, 20258-KShareholder vote5.079.01